Neoplasm Treatment Market Trends

Growth Drivers

Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.
Increasing Geriatric Population - The incidence rates of neoplasms increase with the rise in the elderly population’s percentage. With the increasing age, the cells in the body get damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050, more than 70 percent 80% of the world's old people is anticipated to live in low- and middle-income countries.
Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.
Increasing Geriatric Population - The incidences rates of neoplasm increase as the rise in the elderly population percentage. With the increasing age, the cells in the body gets damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050, more than 70 percent of the world's old people is anticipated to live in low- and middle-income countries.

Challenges

High Cost for the Treatment of Neoplasm - There are treatment options that are critical and needed to be adopted in critical conditions such as surgery. Moreover, the cost charged by the doctors are high for the complex procedures. Therefore, it is expected to hamper the market’s growth in the upcoming years.
Lack of awareness among people in low and middle-income countries for these treatment
Lack of medical reimbursement policies for treatment of Neoplasm

Neoplasm Treatment Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	10.3%
Base Year Market Size (2023)	USD 187.51 Billion
Forecast Year Market Size (2036)	USD 670.67 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of neoplasm treatment is evaluated at USD 204.89 Billion.

The neoplasm treatment market size was valued at USD 187.51 Billion in 2023 and is likely to exceed USD 670.67 Billion by the end of 2036, expanding at over 10.3% CAGR during the forecast period i.e., between 2024-2036. Surging change in genetic mutations, increasing geriatric population are the major factors driving the market growth.

North America is expected to dominate majority industry share by 2036, attributed to rising cases of cancer in the region.

Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.

Neoplasm Treatment Market Trends